SILO PHARMA, INC. Liabilities, Noncurrent
SILO PHARMA, INC. (SILO) had Liabilities, Noncurrent of $631.45 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-08-13
- 2026-03-31: Liabilities, Noncurrent $631.45K.
- 2025-12-31: Liabilities, Noncurrent $649.48K.
- 2025-09-30: Liabilities, Noncurrent $667.50K.
- 2025-06-30: Liabilities, Noncurrent $685.53K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2026-03-31 | $631.45K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $649.48K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $667.50K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $685.53K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $703.55K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $721.58K POS AM · filed 2026-04-14 |
| 2024-09-30 | $739.60K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $757.63K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $775.65K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $793.68K 10-K · filed 2025-03-28 |
| 2023-09-30 | $811.71K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $829.73K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $847.76K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $865.78K 10-K · filed 2024-03-25 |
| 2022-09-30 | $883.81K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $901.83K 10-Q · filed 2022-08-01 |
| 2022-03-31 | $919.86K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $937.88K 10-K · filed 2023-03-24 |
| 2021-09-30 | $955.91K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $973.93K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $946.38K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $4.25K 10-K · filed 2022-03-28 |
| 2020-09-30 | $11.64K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.64K 10-Q · filed 2020-08-14 |
| 2012-12-31 | $15.78K 10-Q · filed 2013-11-14 |
| 2012-09-30 | $15.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $15.00K 10-Q · filed 2012-08-01 |
| 2012-03-31 | $15.00K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $0.00 10-Q · filed 2012-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |